Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 657

Results For "IND"

6841 News Found

Labcorp, a leader in women’s heath solutions acquires Ovia Health
Digitisation | August 13, 2021

Labcorp, a leader in women’s heath solutions acquires Ovia Health

The transaction improves patient experience, patient outcomes and aims to reduce health care costs


Wockhardt to manufacture and supply Sputnik V
News | August 13, 2021

Wockhardt to manufacture and supply Sputnik V

Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19


JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22
News | August 13, 2021

JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22

Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21


Natco Pharma PAT at Rs 75 crore for Q1FY22
News | August 12, 2021

Natco Pharma PAT at Rs 75 crore for Q1FY22

The company has strong product launches both in India and overseas


Mangalam Drugs signs tech transfer agreement with Nigerian pharma company
News | August 12, 2021

Mangalam Drugs signs tech transfer agreement with Nigerian pharma company

Anti-malaria API facility will be operational in 15-18 months


Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
Drug Approval | August 12, 2021

Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness

A treatment to prevent extreme symptoms and cut hospitalisation


Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread
Drug Approval | August 12, 2021

Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread

Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm


Global cell expansion market poised for huge growth
Biotech | August 12, 2021

Global cell expansion market poised for huge growth

Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030


Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
Drug Approval | August 12, 2021

Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee

The company is eligible for 12 months exclusivity from launch


Low-cost flexible tactile sensors for robotics and biomedical applications developed
Drug Approval | August 12, 2021

Low-cost flexible tactile sensors for robotics and biomedical applications developed

The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery